Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 424
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00516607 | Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas | ||
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | ||
| NCT00424164 | Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | ||
| NCT02205047 | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma | ||
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT00002620 | Radiation Therapy in Treating Patients With Brain Cancer | ||
| NCT02307604 | SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access | ||
| NCT05947903 | Validation of the European Oncology Quality of Life Toolkit | ||
| NCT03859453 | Follow-up in Early and Locally Advanced Breast Cancer Patients | ||
| NCT00006230 | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | ||
| NCT00039364 | Imatinib Mesylate in Treating Patients With Gliomas | ||
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | ||
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | ||
| NCT03088059 | Biomarker-based Study in R/M SCCHN | ||
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | ||
| NCT01123473 | Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer | ||
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | ||
| NCT00002462 | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | ||
| NCT06978062 | Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment | ||
| NCT00010153 | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | ||
| NCT01185886 | Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia | ||
| NCT00045019 | Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care | ||
| NCT05209529 | Chemo-free BRCA-targeted Neoadjuvant Strategy | ||
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
| NCT01838577 | Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study | ||
| NCT04708548 | Long Term Implications of Rare Brain Tumours' | ||
| NCT00005868 | Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer | ||
| NCT00006082 | Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer | ||
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | ||
| NCT02051868 | International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel | ||
| NCT00004886 | MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors | ||
| NCT01905592 | A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients | ||
| NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | ||
| NCT02856893 | Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) | ||
| NCT01913652 | Ph II Cabazitaxel DD Liposarcoma | ||
| NCT03515993 | Follow-up in Gynecological Cancer Survivors | ||
| NCT04402073 | Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma | ||
| NCT01942603 | Minimal SN Tumor Burden | ||
| NCT00003803 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | ||
| NCT03443856 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | ||
| NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | ||
| NCT00956072 | Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate | ||
| NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | ||
| NCT01402271 | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | ||
| NCT02546544 | Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma | ||
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | ||
| NCT01288378 | Empirical Versus Preemptive Antifungal Therapy | ||
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | ||
| NCT00003026 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | ||
| NCT00074074 | Infliximab in Treating Patients With Myelodysplastic Syndrome |
